NCT Number: NCT03142971
Shock Wave Therapy for Lateral Hip Pain, Caused by Tendon Pathology
The aim of this randomized controlled study is to investigate if focal shock wave is an effective treatment, with respect to hip pain and lower limb function, in a population affected by greater trochanteric pain syndrome with gluteal tendinopathy.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–80 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- duration of lateral hip pain of six weeks or longer,
- normal passive hip range of movement (ROM),
- sonographic evidence of gluteal tendinopathy at their insertional site at the greater trochanter
Exclusion criteria
- general contraindication to extracorporeal shock wave therapy (pacemaker, pregnancy, bleeding disorders or anticoagulant drug usage, cancer in the focal area),
- history of rheumatologic disease,
- previous fractures or surgery in the affected limb,
- full thickness tear of the gluteal tendons,
- osteoarthritis of the hip (with ROM limitation),
- clinical signs of lumbar radiculopathy,
- corticosteroid injections or other conservative therapies (except pharmacological pain treatments) since the onset of the current pain episode.
Treatment and study plan
ultrasound therapy
ProcedurePrimary outcomes
-
p-NRS
Time frame: Baseline, at two months, at six months
Change from baseline p-NRS (pain-on-movement numeric rating scale) at 2 months and at 6 months.
-
LEFS score
Time frame: Baseline, at two months, at six months
Change from baseline LEFS (Lower extremity functional scale) total score at 2 months and at 6 months
Sponsors and collaborators
Lead sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
Other
Registry information
Official study title
Focused Extracorporeal Shock Wave Therapy for Greater Trochanteric Pain Syndrome With Gluteal Tendinopathy: a Randomized Controlled Trial
Important dates
- Study start
- 2013
- Primary completion
- 2016
- Study completion
- 2016
- First posted
- May 8, 2017
- Registry last updated
- May 10, 2017
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Cartography and Quantitative Characterization of Achilles Tendon Fibrocartilage by TE = 0ms Imaging at 3T MRI
NCT03287596
Arthritis, Bone Diseases
Bordeaux, France
View Trial DetailsEffectiveness of Low-intensity Laser on Pain in Patients With Supraspinatus Tendinopathy.
NCT07261449
Muscular Diseases, Musculoskeletal Diseases
Salamanca, Spain
View Trial DetailsStudy of Efficacy and Safety of AIN457/Secukinumab in Patients With Rotator Cuff Tendinopathy
NCT05569174
Muscular Diseases, Musculoskeletal Diseases
Karlsruhe, Baden-Wurttemberg, Germany
View Trial DetailsStromal Vascular Fraction (SVF) Injection in the Treatment of Patellar Tendinopathy
NCT04753853
Muscular Diseases, Musculoskeletal Diseases
Bologna, Italy
View Trial Details